Molecular dynamics simulations of neutral chlorpromazine in zwitterionic phospholipid monolayers

The Journal of Physical Chemistry. B
Mónica PickholzMunir S Skaf

Abstract

Molecular dynamics simulations have been performed to investigate the interactions between chlorpromazine (CPZ), a neuroleptic drug used in the treatment of psychiatric disorders, and dipalmitoylphosphatidylcholine (DPPC), a zwitterionic phospholipid, in Langmuir monolayers. The results from simulations carried out at different monolayer surface densities were able to capture important features of the CPZ-lipid interaction. We find that neutral (unprotonated) CPZ is preferentially located in the lipid tail region of the phospholipids, in little contact with the aqueous phase, and that the orientation of its rigid ring structure and tail conformation vary with lipid surface density. CPZ is found to promote ordering of the lipid tails for all surface densities because of a reduction in the effective surface area per lipid upon addition of the drug. Similar effects have been observed in previous studies of cholesterol in DPPC monolayers, in which lipid tails were seen to order around the solute. This feature, however, is quite distinct from what we observe for the most dense monolayer considered here (area per lipid of 50 A(2)), for which we find that CPZ promotes a local distortion of the lipid tails in its immediate vicinity and...Continue Reading

References

May 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·D AginD Holtzman
Sep 12, 1998·Biochimica Et Biophysica Acta·S V MalheirosN C Meirelles
Sep 22, 1998·Biophysical Chemistry·S R LouroE Wajnberg
May 8, 1999·Biophysical Journal·R S Cantor
Nov 7, 2000·Biochimica Et Biophysica Acta·J F Nagle, S Tristram-Nagle
Apr 28, 2001·Annual Review of Physical Chemistry·G Richmond
Mar 28, 2002·Biophysical Journal·Yiannis N KaznessisRonald G Larson
Apr 2, 2003·Biophysical Journal·Christofer HofsässOlle Edholm
Jul 12, 2003·Journal of Liposome Research·Hasna AhyayauchMohammed Bennouna
Apr 3, 2004·Biophysical Chemistry·A A HidalgoO N Oliveira
Sep 29, 2004·Biophysical Chemistry·Anna Wisniewska, Agnieszka Wolnicka-Glubisz
Jan 7, 2005·The Journal of Chemical Physics·Daniel DuqueLourdes F Vega
Jan 11, 2005·The Journal of Chemical Physics·Volker KnechtAlan E Mark
Oct 20, 2005·Biophysical Chemistry·Luciana de Matos Alves PintoMaria Angélica Perillo
Jul 21, 2006·The Journal of Physical Chemistry. B·André F de Moura, Milan Trsic
Jul 21, 2006·The Journal of Physical Chemistry. B·Zhiying LiPhillip Choi

❮ Previous
Next ❯

Citations

Jul 10, 2012·Colloids and Surfaces. B, Biointerfaces·Luiz C SalayShirley Schreier
Jun 15, 2010·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Juan José Giner CasaresJosé Javier López Cascales
Jan 30, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·J J Giner-CasaresJ J López Cascales
Jun 2, 2018·Langmuir : the ACS Journal of Surfaces and Colloids·Benjamín CarusoMaría A Perillo
Feb 28, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Heidi M Mansour, George Zografi
Feb 4, 2022·Chemical Reviews·Osvaldo N OliveiraKatsuhiko Ariga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here